Adeptus Biotechnologies Corp. (ADPT) PT Raised to $7.50 at Goldman Sachs
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $24.46 -3.13%
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Goldman Sachs analyst Matthew Sykes raised the price target on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) to $7.50 (from $5.50) while maintaining a Neutral rating.
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- JPMorgan Downgrades Denso Corp. (6902:JP) (DNZOY) to Underweight
- Adyen NV (ADYEN:NA) (ADYYF) PT Raised to EUR1,278 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
